NHS National Framework for Transition products commencing 1 February 2025

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£1
Sector
HEALTH
Published
21 Jan 2025
Delivery
not specified
Deadline
n/a

Concepts

Location

United Kingdom: Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

Geochart for 1 buyers and 6 suppliers

1 buyer

6 suppliers

Description

Project title: NHS National Framework for Transition products commencing 1 February 2025Offer reference number: CM/TNS/24/5713Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.Potential periods of call-offs under the framework agreement:CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide InjectionLot 1 CESW: 01/02/2025 to 31/05/2026 (16 months)Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months)Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

Award Detail

1 Sun Pharma (Uxbridge)
  • Reference: 002071-2025-1
  • Value: £1
2 Thornton & Ross (Huddersfield)
  • Reference: 002071-2025-2
  • Value: £1
3 Drreddys Laboratories (Cambridge)
  • Reference: 002071-2025-3
  • Value: £1
4 Zentiva Pharma (London)
  • Reference: 002071-2025-4
  • Value: £1
5 Biocon (London)
  • Reference: 002071-2025-5
  • Value: £1
6 Baxter Healthcare (Norfolk)
  • Reference: 002071-2025-6
  • Value: £1

Renewal Options

Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months

Award Criteria

price _

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Options are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains